10.1002/anie.202007509
Angewandte Chemie International Edition
RESEARCH ARTICLE
[6]
M. I. Lin, B. H. Su, C. H. Lee, S. T. Wang, W. C. Wu, P. Dangate, S. Y.
Wang, W. I. Huang, T. J. Cheng, O. A. Lin, Y. S. E. Cheng, Y. J. Tseng,
C. M. Sun, Eur. J. Med. Chem. 2015, 102, 477–486.
Conclusion
[7]
[8]
[9]
C. Curti, L. Battistini, A. Sartori, F. Zanardi, Chem. Rev. 2020, 120, 2448–
2612, and references therein.
A novel method has been developed, which allowed the rapid
transformation of easily accessible and low-cost uracil substrates
of type 7 to new three-dimensional carbocycle-fused uracils. The
rationale behind this endeavor was simple: installation of a
carbaldehyde functional group at the C5 site of 6-methyluracil (as
in uracils 7) would enhance the remote enolization at the
vinylogous C6-methyl site, favor the formation of a reactive oQDM
species (an activated diene) for [4 + 2] coupling to an enal
acceptor (dienophile), while providing a possible appendage for
the covalent activation by the amine catalyst. The hypothesis was
confirmed by real-world chemistry and, upon optimized mild
reaction conditions, the route proved practical and
chemodivergent, providing access to two distinct small collections
of products in good yields and almost complete
enantioselectivities namely, bicyclic compounds 9 and tricyclic
products 10, remarkably featuring six contiguous stereocenters.
Detailed DFT calculations and control experiments clarified the
role of the silylprolinol catalyst, which solely and concomitantly
activates both enal substrates and orchestrates the overall
transformation. Mechanistically, a first organocatalyzed stepwise
eliminative [4 + 2] cross cycloaddition between the carbaldehyde
substrates leads to a bicyclic iminium ion intermediate (PC-9aa-
IM), which divergently turns into bicyclic targets 9 by hydrolysis,
or converts to tricyclic targets 10 via a further trienamine-mediated
stepwise [4 + 2] cycloaddition, depending upon the reaction
conditions.
a) B. Yang, S. Gao, Chem. Soc. Rev. 2018, 47, 7926–7953; b) B.-X. Xiao,
X.-Y. Gao, W. Du, Y.-C. Chen, Chem. Eur. J. 2019, 25, 1607-1613.
Y. Liu, M. Nappi, E. Arceo, S. Vera, P. Melchiorre, J. Am. Chem. Soc.
2011, 133, 15212–15218.
[10] a) G. Rassu, C. Curti, V. Zambrano, L. Pinna, N. Brindani, G. Pelosi, F.
Zanardi, Chem. Eur. J. 2016, 22, 12637–12640; b) N. Brindani, G. Rassu,
L. Dell’Amico, V. Zambrano, L. Pinna, C. Curti, A. Sartori, L. Battistini, G.
Casiraghi, G. Pelosi, D. Greco, F. Zanardi, Angew. Chem. 2015, 127,
7494-7498; Angew. Chem. Int. Ed. 2015, 54, 7386–7390; c) for a recent
review on this topic see: C. Curti, A. Sartori, L. Battistini, F. Zanardi,
Synlett 2018, 29, 266–281.
[11] T. Li, J. Zhu, D. Wu, X. Li, S. Wang, H. Li, J. Li, W. Wang, Chem. Eur. J.
2013, 19, 9147–9150.
[12] Interestingly, the presence of lipophilic MOM, MEM, and BOM groups at
N1/N3 uracil moiety highly impacted the physical properties of both the
starting substrates 7 and products 9, which in fact proved much more
soluble in organic solvents as compared to the dimethyl-protected
counterparts.
[13] Deposition Number CCDC 1995936 contains the supplementary
crystallographic data for this paper. These data are provided free of
charge by the joint Cambridge Crystallographic Data Centre and
Fachinformationszentrum Karlsruhe Access Structures service
[14] a) B.J. Bench, C. Liu, C.R. Evett, C.M.H. Watanabe, J. Org. Chem. 2006,
71, 9458–9463; b) C. Grondal, M. Jeanty, D. Enders, D. Nat. Chem. 2010,
2, 167–178; c) N. Hammer, L.A. Leth, J. Stiller, M.E. Jensen, K.A.
Jørgensen, Chem. Sci. 2016, 7, 3649-3657; d) S. Meninno, M. Meazza,
J.W. Yang, T. Tejero, P. Merino, R. Rios, Chem. Eur. J. 2019, 25, 7623–
7627.
[15] DFT computational investigation of the relevant reactions involved in this
work was carried out at the M06-2X/6-311++g(d,p) IEFPCM
(CH2Cl2)//M06-2X/6-31G(d) level of theory. For details, see Supporting
Information.
We anticipate that this robust and simple chemical transformation
will serve to widen sampling of three-dimensional chemical space
around the key uracil core.
[16] S. Bahmanyar, K.N. Houk, J. Am. Chem. Soc. 2001, 123, 11273-11283.
[17] Water content in commercial benzoic acid used in this work, either as a
solid or in CH2Cl2 solution, was determined via Karl Fischer titration (KF)
and resulted 0.53% and 0.02%, respectively. Also, reaction of 7a and 8a
with H2O (7.0 equiv) and in the absence of benzoic acid led to the almost
exclusive formation of 9aa; these experiments allowed us to exclude an
active role of water in controlling chemoselectivity. Interestingly, KF
titration of a control reaction between 7a and 8a (under the optimized
conditions in Table 1, entry 14) revealed the formation of water (0.5
equiv) after 12 hours (ca 50% conversion), thus confirming the proposed
catalytic cycle shown in Scheme 5, where 1 equiv of water is formed in
either catalytic cycle. We thank a reviewer for drawing this point to our
attention.
Acknowledgements
This work was supported by Regione Autonoma della Sardegna
(RASSR81788, 2017, “Green Chemistry in Drug Discovery -
sintesi sostenibili di nuovi inibitori di telomerase”) and by
Università di Parma (ZNRFNC_RICERCA_IST). G.P. wishes to
thank Chiesi Farmaceutici S.p.A. for the use of D8Venture
diffractometer. Thanks are due to Centro Interdipartimentale
Misure “G. Casnati” (Università di Parma, Italy) for instrumental
facilities. We thank M. Cito (Department of Food and Drug,
University of Parma) for Karl Fischer titration measurements.
Keywords: asymmetric synthesis • fused-ring systems •
heterocycles • organocatalysis • vinylogy
[1]
[2]
Y. Qin, L. Zhu, S. Luo, Chem. Rev. 2017, 117, 9433–9520.
D. C. Blakemore, L. Castro, I. Churcher, D. C. Rees, A. W. Thomas, D.
M. Wilson, A. Wood, Nat. Chem. 2018, 10, 383–394.
[3]
[4]
T. L. P. Galvão, I. M. Rocha, M. D. M. C. Ribeiro da Silva, M. A. V. Ribeiro
da Silva, J. Phys. Chem. A 2013, 117, 5826–5836.
S. I. Zav’yalov, G. I. Ezhova, N. E. Kravchenko, L. B. Kulikova, O. V.
Dorofeeva, E. E. Rumyantseva, A. G. Zavozin, Pharm. Chem. J. 2003,
37, 337–341.
[5]
a) E. De Clercq, J. Med. Chem. 2019, 62, 7322–7339; b) A. Pałasz, D.
Cież, Eur. J. Med. Chem. 2015, 97, 582–611.
10
This article is protected by copyright. All rights reserved.